In a study published today in the Journal of Clinical Investigation, Fred Hutch Cancer Center cancer chemical biologist ...
A study has found targeting a protein called endocan and its related signaling pathway could be a promising new approach for treating glioblastoma, an aggressive and lethal type of brain cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback